City

Riyadh (1)

Condition

Moderate Covid19 (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

King Abdullah International Medical Research Center (1)

Collaborator

Intervention

leukotriene receptor antagonist (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

moderate covid19

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Moderate Covid19 Trial in Riyadh (Leukotriene Receptor Antagonist, Placebo)

Recruiting

Moderate Covid19

Leukotriene Receptor Antagonist
Placebo

Riyadh, Saudi Arabia

King Abdulaziz Medical city, MNGHA

May 5, 2021